Neurology Perspective

 
 
  • ISC 2025 Thrombectomy in Distal Stroke Overreach or Fine Tuning?   The DISTAL and ESCAPE MeVO trials were neutral for thrombectomy in distal vessel occlusions — were the patients who would benefit simply not enrolled and what will the investigators do going forward?
  • ACC 2025 Little Learned From Trials That Are Positive by Design Dapagliflozin after TAVI? Semaglutide for claudication? Two trials designed to be positive should not warrant new indications for these drugs writes John Mandrola, MD.
  • For America First, Invest in Science and the NIH   Panel discussion of a Presidential Advisory from the American Heart Association that outlines the importance of funding for scientific research and the need for a robust National Institutes of Health.
  • How Migraine Treatment Guidelines Differ: ACP vs AHS   Dr Neil Skolnik explains the ACP's new clinical guideline for the prevention of episodic migraines — and how it differs from the recent AHS position statement.
  • Spasticity in MS: Integrating Rehab and Medical Treatments Dr Francois Bethoux, MD, and physical therapist Patricia Bobryk discuss multidisciplinary approaches for spasticity in multiple sclerosis.
  • GLP-1 Drugs Might Cut Dementia Risk in Half   New evidence brings more good news about the unanticipated effects of the GLP-1 receptor agonists.
  • ED EMR Data Supports People With Disabilities in Emergencies Accurate health data are essential to ensure that people with disabilities receive the care, support, and resources they need during public health emergencies.
  • Apr 04 2025 This Week in Cardiology   Trials from the 2025 American College of Cardiology scientific sessions, including the WARRIOR, PROTECT TAVI, DAPATAVI, and SOUL are reviewed by John Mandrola, MD
  • Should Medicine Be Boring? Heroic high-stakes medicine should be left to TV doctors, because the most effective care is performed with a level of precision bordering on the mechanical and the mundane.
  • Gene Therapy: Medical Progress Has a Price, Says Ethicist   Ethicist Art Caplan discusses progress in gene therapy research and the need for medical professionals and regulators to tolerate appropriate risk.
  • Mar 28 2025 This Week in Cardiology   Stopping oral anticoagulation after AF ablation, the core problem with paradoxes like the smoker’s paradox, chronic total occlusion PCI, and an ACC/EHRA preview are discussed by John Mandrola, MD, in this week’s podcast.
  • Medscape Neurologists and Suicide Report 2025 Neurologists reveal whether they, or colleagues, have contemplated suicide. They also discuss factors behind the suicide issue and where doctors can turn for help.
  • The Ethical Consequences of the New Administration   Ethicist Art Caplan discusses the ethical consequences of the new administration.
  • ACC 2025 Mandrola’s 5 Picks for ACC 25 Trials on cerebral protection in TAVR, fluid restriction in heart failure, and risk factor management in AF are among John Mandrola’s picks from the upcoming ACC Scientific Sessions.
  • When to Invite a Third Person Into the Room When should the patient-clinician dyad become a triad? A resident neurologist ponders the question in the context of the aging patient population.
  • Improving Cognitive Outcomes in Multiple Sclerosis   Drs Frederick Foley and John DeLuca share clinical insights for the assessment and treatment of cognitive dysfunction in multiple sclerosis.
  • Conference MDAngle: AAN 2025 Myasthenia Gravis Dr Nicholas Silvestri shares AAN 2025 highlights, including anticipated presentations, quick takeaways, and insights on the impact of new myasthenia gravis research.
  • AAN 2025: Anticipating New Approaches in Myasthenia Gravis   Dr Nicholas Silvestri looks ahead to new data on existing agents and emerging therapies for myasthenia gravis.
  • US Falls Behind Other Countries in Avoidable Deaths   It just doesn’t work to keep throwing money at poor health outcomes.
  • S3 Episode 3: The 2025 updates of the American Diabetes Association   Drs Carol H. Wysham and Rozalina G. McCoy discuss the 2025 updates of the American Diabetes Association, including comorbidities, dental care, sexual dysfunction, and CGM use.